Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUR-1008 Administration Mode in Infants with CF
NCT01100606Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Jun 2010
- Primary completion
- Dec 2010
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pancreatin in exocrine pancreatic insufficiency (EPI), sponsored by Forest Laboratories. Started Jun 2010; status: completed.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT01100606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100606.